Drugs / ORV 116E
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT01305109 | Mar 2011 → Dec 2013 | Rotavirus infection | Bharat Biotech International Limited | Unknown | Met primary |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | ORV 116E | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01305109 ↗ |
| Modality | Vaccine | “three doses of oral human-bovine natural reassortant vaccine (116E)” PMID 24629994 ↗ Mar 2014 |
| Route | Oral | “Oral Rotavirus Vaccine 116E (ORV 116E)” NCT01305109 ↗ |